搜索页_+Irinotecan

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

常用资源

在“SpringerLink电子期刊”中，命中：1,270条，耗时：小于0.01 秒

1. Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues

作者： Bronwen J. Mayo ; Andrea M. Stringer…

关键词：Gastrointestinal mucositis ; Irinotecan ; Glucagon ; like peptide2 ; Apoptosis ; Proliferation ; Inflammation

刊名：Cancer Chemotherapy and Pharmacology

出版年：2017

2. Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration

作者： S. Kenneth Sy ; Theresa D. Sweeney ; Chunmei Ji…

关键词：Etirinotecan pegol ; Irinotecan ; SN38 ; Neutropenia ; Breast cancer ; NKTR ; 102

刊名：Cancer Chemotherapy and Pharmacology

出版年：2017

3. Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report

作者： Janet K. Coller ; Joanne M. Bowen ; Imogen A. Ball…

关键词：Irinotecan ; TLR4 antagonist ; Gut toxicity ; Efficacy

刊名：Cancer Chemotherapy and Pharmacology

出版年：2017

4. Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)

作者： N. Kentepozidis ; P. Economopoulou…

关键词：Platinum ; based chemotherapy ; Advanced NSCLC ; Irinotecan/cisplatin ; Pemetrexed/cisplatin ; Second ; line treatment

刊名：Clinical and Translational Oncology

出版年：2017

5. Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer

作者： Jesper Andreas Palshof ; Estrid Vilma Solyom Høgdall ; Tim Svenstrup Poulsen…

关键词：Biomarker ; Colorectal cancer ; FISH ; Gene copy number ; Irinotecan ; Topoisomerase I

刊名：BMC Cancer

出版年：2017

6. Development of LC–MS/MS Method for Simultaneous Determination of Irinotecan and Its Main Metabolites in Rat Plasma, and Its Application in Pharmacokinetic Studies

作者： Nanxi Wang ; Chaoran Zhu ; Xuejia Zhai ; Xinlin Zhang ; Yanjie Qin…

关键词：LC–MS/MS ; Irinotecan ; Metabolites ; Pharmacokinetics ; Personalized medicine

刊名：Chromatographia

出版年：2017

7. Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study

作者： Noor Al-Dasooqi ; Joanne Bowen ; Colin Bennett ; John Finnie…

关键词：Alimentary tract ; Chemotherapy ; Adhesion proteins ; Histopathology ; Mucositis

刊名：Supportive Care in Cancer

出版年：2017

8. NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma

作者： Mark R. Gilbert ; Stephanie L. Pugh ; Ken Aldape…

关键词：Glioblastoma ; Anti ; angiogenic treatment ; Randomized trial ; Combination therapy

刊名：Journal of Neuro-Oncology

出版年：2017

9. Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study

作者： Francis Lévi ; Abdoulaye Karaboué…

刊名：Clinical Pharmacokinetics

出版年：2017

10. Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study)

作者： Masato Nakamura ; Toru Aoyama ; Keiichiro Ishibashi…

关键词：Cetuximab ; KRAS G13D ; Colorectal cancer

刊名：Cancer Chemotherapy and Pharmacology

出版年：2017

按检索点细分(1270)

题名(675)

关键词(494)

文摘(1046)

按出版年细分(1270)

2017年(19)

2016年(73)

2015年(106)

2014年(97)

2013年(107)

2012年(72)

2011年(62)

2010年(66)

2009年(94)

2008年(93)

2007年(85)

2006年(80)

2005年(82)

2004年(66)

2003年(38)

2002年(16)

2001年(33)

2000年(26)

2000年及以前(55)